Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Geographic Atrophy > Early indicators of geographic atrophy identified in intermediate AMD using AI-Based OCT imaging
  • Geographic Atrophy

Early indicators of geographic atrophy identified in intermediate AMD using AI-Based OCT imaging

Kelsey Moroz

Thinning of photoreceptors and the outer nuclear layer, detectable via high-precision AI-based optical coherence tomography, serves as an early indicator of outer plexiform layer subsidence, which precedes geographic atrophy in intermediate age-related macular degeneration (iAMD), according to a study.

The study involved 280 eyes from 140 participants with bilateral iAMD who were part of a multicenter clinical trial. Over a 36-month follow-up period, AI was used to segment and analyze changes in photoreceptor (PR) and outer nuclear layer thickness, drusen height, and choroidal hypertransmission. These measurements were taken every 6 months.

Outer plexiform layer subsidence occurred in 53 eyes from 43 participants; 36 of these eyes went on to develop retinal pigment epithelium and outer retinal atrophy. Before the onset of OPL subsidence, PR and ONL thicknesses were significantly thinner in areas of OPL subsidence compared to those with drusen or reference areas (PR: 20 µm vs 23 µm and 27 µm; ONL: 84 µm vs 94 µm and 98 µm). The study also noted accelerated thinning rates of PR (0.6 µm/month) and outer nuclear layer (0.8 µm/month) in regions of outer plexiform layer subsidence.

The study’s findings underscore the potential of AI to predict and quantify early morphological changes that precede the onset of GA.

Reference
Riedl S, Schmidt-Erfurth U, Rivail A, et al. Sequence of Morphological Changes Preceding Atrophy in Intermediate AMD Using Deep Learning. Invest Ophthalmol Vis Sci. 2024;65(8):30. doi: 10.1167/iovs.65.8.30. PMID: 39028907.

 

This content is independent editorial sponsored by Astellas. Astellas had no input in the development of this content.

Share

Related Content

  • Geographic Atrophy

Geographic atrophy linked to vision loss, higher healthcare costs, and fall risk

  • Geographic Atrophy

Spotlight on IZERVAY®

  • Geographic Atrophy

Two-year GATHER2 data show sustained GA growth reduction with avacincaptad pegol

  • Conference Roundup

Floretina 2025: study shows reduced treatment burden with EYP-1901 for neovascular AMD

3 Mins Watch
  • Geographic Atrophy

Over half of patients with dry AMD developed advanced disease in long-term analysis

  • Geographic Atrophy

Monthly avacincaptad pegol reduces geographic atrophy lesion growth for up to 3.5 years

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon